MRI features of hepatic metastasis from hepatoid adenocarcinoma of the stomach: A case report

Yuan, Jie; Wang, Guonian; Liu, Mengxiao; Gong, Zhigang

doi:10.1016/j.radcr.2022.04.011

Cited by 2 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…AFP can also be used as an important reference index for post-treatment follow-up of HAS patients. A clear diagnosis before surgery is the primary prerequisite for formulating a correct treatment plan, and enhancement CT and MRI scans are important imaging method for the diagnosis of HAS [1,10,11]. In this patient, the lesions in the antrum and liver were clearly observed on preoperative CT, and the arterial phase enhancement was evident.…”

Section: Discussionmentioning

confidence: 73%

Hepatoid Adenocarcinoma of the Stomach with Liver and Pulmonary Metastases: A Case Report and Literature Review

Peng,

Zeng,

Qiao

et al. 2024

J Biomed Res Environ Sci

View full text Add to dashboard Cite

Hepatoid Adenocarcinoma of the Stomach (HAS) is a rare unique subtype of Gastric Cancer (GC) with a low incidence but a high mortality rate. We report a female case of 67-years-old with APF producing hepatoid adenocarcinoma of the gastric antrum with liver and lung metastases. Abdominal CT of the patient showed multiple liver masses, which were considered as metastatic tumors and proved to be adenocarcinoma by pathological examination of a biopsy. The gastroscopy revealed antral ulcer complicated with bleeding. The biopsy results of hepatoid adenocarcinoma were consistent with the results of liver masses. Moreover, α-Fetoprotein (AFP) increased sharply to 86332 ng/mL. Thus, the diagnosis of gastric hepatoid adenocarcinoma with liver metastasis was established. In terms of treatment, liver TACE embolization was performed first, followed by radical gastrectomy and resection of liver tumor. During the operation, multiple small tumors (less than 5cm in diameter) in the liver were treated by radiofrequency ablation. The patient recovered well after surgery, with a rapid decline in AFP. Postoperative CT indicated the presence of bioactive tumors in the liver and new tumors in the lung. Lung puncture pathology suggests tumor metastasis. Liver and lung were treated with radiofrequency ablation and SOX (Oxaliplatin and Tegacil) chemotherapy. There was no significant recurrence 20 months after surgery, and personalized systematic treatment for this patient was effective. Standard treatment for gastric hepatoid adenocarcinoma has not yet been established, and personalized systematic therapy is the preferred treatment.

show abstract

Section: Discussionmentioning

confidence: 73%